The Oncology Institute, Inc. TOI Operating Lease Weighted Average Discount Rate Percent

Operating Lease Weighted Average Discount Rate Percent at other companies

Option Care Health, Inc.OPCH

——

Inhibrx Biosciences, Inc.INBX

——

Revenue$147.4M+41.2%

Operating income-$6.5M+34.3%

Net income-$2.5M+87.3%

EPS (diluted)-$0.02+90.5%

Cash & equivalents$30.3M-23.8%

Total debt$104.9M+2.5%

Total equity-$16.3M-421%

Total assets$168.2M+2.6%

Operating cash flow-$2.2M+55.6%

CapEx$1.0M+218%

Free cash flow-$3.3M+38.7%

Market cap$511.91M+133%

Enterprise value$586.58M+108%

P/S0.9×+0.4×

Operating margin-6%-2.1pp

Net margin-8%-2.7pp

FCF margin-5.1%—

Return on equity-277.6%-700pp

Debt / equity20.2×+17.3×

Current ratio1.5×-0.3×

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is The Oncology Institute, Inc.'s operating lease weighted average discount rate percent?: The Oncology Institute, Inc. (TOI) reported operating lease weighted average discount rate percent of $0.07 in Q1 2026.
How has The Oncology Institute, Inc.'s operating lease weighted average discount rate percent changed year-over-year?: The Oncology Institute, Inc.'s operating lease weighted average discount rate percent increased by 3.3% year-over-year, from $0.07 to $0.07.